All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: A matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies

1. Sanz, M.A.
2. Montesinos, P.
3. Kim, H.T.
4. Ruiz-Argüelles, G.J.
5. Undurraga, M.S.
6. Uriarte, M.R.
7. Martínez, L.
8. Jacomo, R.H.
9. Gutiérrez-Aguirre, H.
10. Melo, R.A.M.
11. Bittencourt, R.
12. Pasquini, R.
13. Pagnano, K.
14. Fagundes, E.M.
15. Vellenga, E.
16. Holowiecka, A.
17. González-Huerta, A.J.
18. Fernández, P.
19. De La Serna, J.
20. Brunet, S.
21. De Lisa, E.
22. González-Campos, J.
23. Ribera, J.M.
24. Krsnik, I.
25. Ganser, A.
26. Berliner, N.
27. Ribeiro, R.C.
28. Lo-Coco, F.
29. Löwenberg, B.
30. Rego, E.M.
31. Mostrar todos los/as autores/as +